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(1) Plasma from mice heavily parasitized by Plasmodium vinckei vinckei was found to contain micromolar 
levels of iron as detected by the ‘bleomycin assay’ (slightly modified) of Gutteridge et al. [( 198 1) Biochem. 
J. 199, 263-2651. Uninfected mouse plasma contained little or no bleomycin-detectable iron. (2) Plasma ul- 
trafiltrate from infected mice contained no bleomycin-detectable iron, indicating that such iron was associat- 
ed with the protein/macromolecule fraction. (3) We speculate that this iron could catalyse reduction of per- 
oxides in vivo and thus play a role in malaria pathology. 
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1. INTRODUCTION 
Malaria is caused by intra-erythrocytic parasites 
that induce hemolysis and extensive damage to 
parenchymatous organs and endothelial cells [ 11. It 
has been proposed that this tissue damage, and 
also the appearance of degenerating parasites 
(‘crisis forms’) within erythrocytes during the 
natural course of the infection, are mediated by 
soluble factors secreted by phagocytes [2]. These 
crisis forms can be artificially induced by injection 
of oxidative drugs such as alloxan, t-butyl 
hydroperoxide, divicine and Hz02 [3-71. Both this 
type’ of drug [4,8], and activated macrophages 
[9,10], have been shown to place lethal oxidative 
stress on intra-erythrocytic parasites in vitro. 
These observations upport the suggestion [3] that 
reactive oxygen species contribute to the host’s im- 
mune response to malaria. 
The observation that the anti-parasitic and 
hemolytic activity of these drugs is blocked by the 
iron chelator desferrioxamine [3-51 raises the 
possibility that iron, by catalysing the reduction of 
Hz02 and organic peroxides, plays a significant 
role in the tissue damage seen in malaria, which is 
similar to that found in iron overload conditions 
[ 111. Iron-dependent damage to DNA by 
bleomycin (Blm) has been used to determine levels 
of catalytic iron in biological samples [12,131. Blm 
binds to DNA and chelates available Fe3+ (Ka = 
10” [14]). Chemical reduction of the chelated iron 
to Fe’+ in the presence of oxygen causes oxidative 
damage to DNA and the formation of thiobar- 
bituric acid-reactive material [ 15,161. 
Here we report the detection, using a slight 
modification of this method, of potentially 
catalytic iron in plasma from Plasmodium vinckei 
vinckei-infected mice. 
2. MATERIALS AND METHODS 
CBA/CaH mice of either sex and 7-9 weeks of 
age were used throughout. P. vinckei vinckei 
(strain V52, from F.E.G. Cox) was maintained by 
i.p. injection of lo6 parasitized erythrocytes. Blood 
was drawn into heparin (20 units/ml). 
Pure Blm Bz was the generous gift of Dr N. 
Hart, Division of Applied Organic Chemistry, 
CSIRO, Melbourne. Blenoxane was from Bristol 
Labs, Bristol, England, calf thymus DNA (type I) 
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and mouse hemoglobin (type X) from Sigma, L- 
ascorbic acid (Analar) from BDH Chemicals and 
Chelex-100 (200-400 mesh) from BioRad. 
The assay for catalytic iron, based on Blm- 
induced damage to DNA [ 121, was modified slight- 
ly. Pure Blm Bz was used instead of the mixture of 
Blm A2 and BZ types found in blenoxane or Blm 
sulfate. Solutions containing chelex 100 were cen- 
trifuged (10000 x g, 30 min, 4°C) before use. 
FeCl3 standards were made up freshly in chelex 
lOO-treated Hz0 and added within 3 min to in- 
cubation tubes containing Blm. Samples were 
preincubated for 5 min before addition of ascorbic 
acid, followed by a 2 h incubation at 37°C. It was 
found necessary to centrifuge samples (1500 x g, 
10 min) after HCVthiobarbituric acid boiling 
treatment before spectrophotometric determina- 
tions. Absorbance changes were determined by the 
difference spectrum &2-600 against a blank con- 
taining all components except Blm and sample. 
Samples were assayed in duplicate in the presence 
and absence of Blm. Plasma from 4-5 mice 
(parasitemia 75-90%) was ultrafiltered using an 
Amicon Centrifree micropartition system (1500 x 
g, 2 h, 4”C, Sorvall SS-34 rotor, angle 34”). 
Hemoglobin was assayed as described [17]. 
3. RESULTS AND DISCUSSION 
Fig.1 shows a representative assay standard 
curve, using FeC13 for Blm-dependent damage to 
DNA. The linearity found at low concentrations of 
FeC13 is in agreement with others [12], although 
the magnitude of the response is somewhat lower. 
This deviation may be a function of the particular 
type of Blm used. The reactivity of different Blm 
types is illustrated by the standard curve using 
blenoxane (fig.l), which contains approx. 70% 
Blm AZ and 30% Blm Bz. 
Normal mouse plasma, like normal human 
serum [13], contained little or no detectable Fe3+ 
(table la), whereas plasma from mice carrying a 
high parasite load (75-70% of red cells infected) 
contained significant amounts (88-150 PM). 
Chelation by heparin could have artificially 
lowered these readings, but they are still ap- 
preciable. It is unlikely that these high levels repre- 
sent free ionic iron alone. To see if we were detec- 
ting protein-bound iron, plasma from control and 
P. vinckei vinckei-infected mice was ultrafiltered 
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Fig. 1. Bleomycin-Fe3+ dependent degradation of DNA. 
Dose-response curve for the FeCls-dependent formation 
of thiobarbituric acid-reactive material from DNA in the 
presence of Blm. Samples were assayed as described in 
section 2. (A) Control, no bleomycin; (0) Blm Bz; (+) 
blenoxane . 
Table 1 
Bleomycin B2-detectable Fe3+ in malaria plasma 
(a) Plasma 
Control mice 
Infected mice 
3.3 + 4.4 (6) 
118.2 f 28.8 (5) 
(b) Ultrafiltration 
Sample Control Infected 
Plasma 
Ultrafiltrate 
Non-ultrafiltrable 
material 
0 88 
3 4 
5 73 
Bleomycin-detectable Fe3+ was determined as described 
in section 2. (a) Plasma from control and P. vinckei 
vinckei-infected mice. (b) Ultrafiltration of plasma from 
control and P. vinckei vinckei-infected mice. 
Ultrafiltrate was > 99% hemoglobin and protein-free. 
Values are expressed as micromolar Fe’+, mean f SD (n) 
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before assaying it for Blm-detectable iron. Negligi- 
ble amounts were found in the filtrate or plasma 
residue from uninfected mice or the plasma filtrate 
from infected animals. In contrast, the plasma 
residue from infected mice contained about 80% 
of the total Blm-detectable iron found in unfrac- 
tionated plasma (table lb), suggesting that the iron 
found in plasma from infected animals is 
associated with a protein or macromolecule com- 
plex(es), where the binding constant is similar to, 
or less than, that of the iron-Blm complex. Pure 
mouse hemoglobin did not release iron to 
bleomycin (not shown). Some of this bound iron 
evidently has at least one co-ordination site oc- 
cupied by an easily displaceable ligand, such as 
Hz0 [ 181, since it can act catalytically to reduce 
peroxides [3,4,8]. 
Within these constraints, it is suggested that the 
iron detected by the Blm assay in plasma from 
malaria-infected mice could catalyze reduction of 
peroxides in vivo to products that might be partial- 
ly responsible for the tissue damage associated 
with the infection. 
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